XML 71 R57.htm IDEA: XBRL DOCUMENT v3.24.1
FINANCIAL INSTRUMENTS (Tables)
12 Months Ended
Dec. 31, 2023
FINANCIAL INSTRUMENTS  
Schedule of financial assets and financial liabilities

Fair value

    

    

accounted

    

accounted

    

through

through other

Amortized

 profit or

comprehensive

As of December 31, 2023

cost

 loss

Income

Total

Assets

  

  

  

Cash and cash equivalents

126,516

33,258

159,774

Investments

12,110

111,859

123,969

Trade receivables

133,120

133,120

Other receivables

21,615

10

1,986

23,611

Total

293,361

145,127

1,986

440,474

Liabilities

  

Trade payables

357,768

357,768

Borrowings

2,128,069

2,128,069

Leases liabilities

88,645

88,645

Other liabilities

14,346

1,593

15,939

Total

2,588,828

1,593

2,590,421

Fair value

    

    

accounted

    

accounted

    

through

through other

Amortized

profit or

comprehensive

As of December 31, 2022

cost

loss

Income

Total

Assets

  

  

  

  

Cash and cash equivalents

99,563

25,162

124,725

Investments

26,074

26,074

Trade receivables

117,507

117,507

Other receivables

5,585

7,631

990

14,206

Total

222,655

58,867

990

282,512

Liabilities

  

Trade payables

278,946

278,946

Borrowings

1,461,033

1,185

(1,127)

1,461,091

Leases liabilities

89,987

89,987

Other liabilities

2,453

2,227

4,680

Total

1,832,419

3,412

(1,127)

1,834,704

Schedule of gains and losses of financial instruments by category

Gains and losses by category – Year 2023

    

Net gain/(loss)

    

Of which interest

Financial assets at amortized cost

63,196

24,823

Financial liabilities at amortized cost

(758,092)

(22,142)

Financial assets at fair value through profit or loss

88,770

64,323

Financial liabilities at amortized cost through profit or loss

(31,136)

Total

(637,262)

67,004

Gains and losses by category – Year 2022

    

Net gain/(loss)

    

Of which interest

Financial assets at amortized cost

18,143

14,216

Financial liabilities at amortized cost

63,960

(51,759)

Financial assets at fair value through profit or loss

(29,848)

(2,283)

Financial liabilities at amortized cost through profit or loss

(17,233)

Total

35,022

(39,826)

Gains and losses by category – Year 2021

    

Net gain/(loss)

    

Of which interest

Financial assets at amortized cost

 

38,403

 

8,025

Financial liabilities at amortized cost

 

159,397

 

(134,267)

Financial assets at fair value through profit or loss

 

4,288

 

570

Financial liabilities at fair value through profit or loss

 

(17,124)

 

Total

 

184,964

 

(125,672)

Schedule of financial assets and liabilities recognized at fair value and the level of hierarchy

As of December 31, 2023

    

Level 1

    

Level 2

    

Total

Assets

 

  

 

  

 

  

Current Assets

 

  

 

  

 

  

Mutual Funds (1) (2)

 

14,426

 

 

14,426

Government bonds (1) (2)

 

130,691

 

 

130,691

Other receivables: DFI (3)

 

 

1,549

 

1,549

Other receivables: Indemnification assets (4)

 

 

10

 

10

Non-current Assets

 

 

 

Other receivables: DFI (3)

 

 

437

 

437

Total assets

 

145,117

 

1,996

 

147,113

Liabilities

 

  

 

  

 

  

Current Liabilities

 

  

 

  

 

  

Other liabilities: Debt for acquisition of NYSSA

 

 

567

 

567

Borrowings: DFI

 

 

 

Non-current Liabilities

 

  

 

 

Other liabilities: Debt for acquisition of NYSSA

 

 

1,026

 

1,026

Total liabilities

 

 

1,593

 

1,593

As of December 31, 2022

 

Level 1

 

Level 2

 

Total

Assets

 

  

 

  

 

  

Current Assets

 

  

 

  

 

  

Mutual Funds (1) (2)

 

17,966

 

 

17,966

Government bonds (1) (2)

 

40,790

 

 

40,790

Other receivables: DFI (3)

365

365

Other receivables: Indemnification assets (4)

109

109

Non-current Assets

 

 

 

Other receivables: DFI (3)

627

627

Total assets

58,756

1,101

59,857

Liabilities

 

  

 

  

 

Current Liabilities

 

  

 

  

 

Other liabilities: Debt for acquisition of NYSSA

 

 

613

 

613

Borrowings: DFI

58

58

Non-current Liabilities

Other liabilities: Debt for acquisition of NYSSA

1,614

1,614

Total liabilities

 

 

2,285

 

2,285

(1)

The Mutual funds are included in Cash and cash equivalents, Investments and Guarantee of financial operations included in Other receivables. The Government bonds are included in Cash and cash equivalents and Investments.

(2)

The fair value is based on information obtained from active markets and corresponds to quoted market prices as of year-end. A market in which transactions for the asset or liability take place with sufficient frequency and volume to provide pricing information on an ongoing basis.

(3)

The fair value of financial instruments that are not negotiated in active markets is determined using valuation techniques. These valuation techniques maximize the use of market observable information, when available, and rely as little as possible on specific estimates of the Company. The techniques used for the measurement of financial instruments, are detailed below: a) DFI for forward purchases of US dollars and RMB, corresponds to the variation between the market prices at the end of the fiscal year and the time of agreement and; b) DFI interest rate swap corresponds to the present value of estimated future cash flows based on observable yield curves obtained in the market.

(4)

The fair value was determined by the variation between the quoted values of certain public securities in foreign currency and Argentine pesos.

Schedule of fair value of financial debt

As of December 31, 2023, fair value of borrowings is as follows:

    

Carrying Value

    

Fair Value

Notes

 

1,305,742

 

1,210,111

Other borrowings

 

822,327

 

828,547

 

2,128,069

 

2,038,658

As of December 31, 2022, fair value of borrowings is as follows:

    

Carrying Value

    

Fair Value

Notes

 

835,024

 

846,820

Other borrowings

 

626,067

 

612,754

 

1,461,091

 

1,459,574

Schedule of position of DFIs in the consolidated statements of financial position and amounts recognized in Consolidated Income Statements and Consolidated Statements of Comprehensive Income

As of December 31,

2023

2022

Other receivables current - DFI: SOFR

    

1,549

    

365

Other receivables non current - DFI: SOFR

 

437

 

627

Total assets

 

1,986

 

992

Borrowings current - DFI: Exchange rate

 

 

58

Total liabilities

 

 

58

Years ended December 31,

2023

2022

2021

Profit (loss)

Foreign currency exchange effect on borrowings

    

7,932

    

(4,842)

    

(11,108)

Interests on borrowings

 

(1,243)

 

(458)

 

(2,292)

Financial results

 

6,689

 

(5,300)

 

(13,400)

DFI effects classified as hedges

 

1,313

 

1,893

 

2,074

Other comprehensive income (loss)

 

1,313

 

1,893

 

2,074

Schedule of offsetting of financial assets and financial liabilities in scope of IFRS 7

As of December 31, 2023

Trade

Other

Other

    

receivables

    

receivables

    

Trade payables

    

liabilities

Current and noncurrent assets (liabilities) - Gross value

 

140,402

 

24,483

 

(365,050)

 

(16,811)

Offsetting

 

(7,282)

 

(872)

 

7,282

 

872

Current and noncurrent assets (liabilities) – Carrying Value

 

133,120

 

23,611

 

(357,768)

 

(15,939)

As of December 31, 2022

Trade

Other

Other

    

receivables

    

receivables

    

Trade payables

    

liabilities

Current and noncurrent assets (liabilities) - Gross value

 

125,096

 

15,626

 

(286,535)

 

(6,100)

Offsetting

 

(7,589)

 

(1,420)

 

7,589

 

1,420

Current and noncurrent assets (liabilities) – Carrying Value

 

117,507

 

14,206

 

(278,946)

 

(4,680)